Multiple myeloma screening involves blood and urine tests to detect abnormal monoclonal proteins produced by malignant plasma cells, aiding early diagnosis of this bone marrow cancer. Early identification is crucial to prevent complications like bone fractures and renal failure. Screening is especially important in patients with unexplained anaemia, bone pain, or elevated calcium levels.